Cargando…
Towards building a tuberculosis free world
The Honourable Prime Minister of India set a target of year 2025 for elimination of TB from the country, 5 years ahead of the Sustainable Development Goal of 2030. Last few years, India has made significant improvements, towards elimination of tuberculosis from the country in the form of bold polici...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. on behalf of Tuberculosis Association of India.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231385/ https://www.ncbi.nlm.nih.gov/pubmed/35760473 http://dx.doi.org/10.1016/j.ijtb.2021.08.018 |
_version_ | 1784735326138269696 |
---|---|
author | Mandal, Sudarsan |
author_facet | Mandal, Sudarsan |
author_sort | Mandal, Sudarsan |
collection | PubMed |
description | The Honourable Prime Minister of India set a target of year 2025 for elimination of TB from the country, 5 years ahead of the Sustainable Development Goal of 2030. Last few years, India has made significant improvements, towards elimination of tuberculosis from the country in the form of bold policies and unprecedented political commitment. While COVID-19 has resulted in setbacks for TB elimination efforts, it has also offered an opportunity to revisit and structurally redesign the public health infrastructure/system in our country. The dream of TB elimination is possible with active participation of all stakeholders and community at large coupled with accelerated development of new diagnostics, drugs, and development of a new TB vaccine. COVID-19 pandemic has shown that vaccines can be developed in a year, contrarily, the lack of a TB vaccine is deterrent in the efforts towards a TB free world. A progress towards TB elimination would require potential contribution of novel TB vaccine. Now, is the time for mobilization towards a TB vaccine to make an impact towards our end TB goal. |
format | Online Article Text |
id | pubmed-9231385 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier B.V. on behalf of Tuberculosis Association of India. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92313852022-06-27 Towards building a tuberculosis free world Mandal, Sudarsan Indian J Tuberc Editorial The Honourable Prime Minister of India set a target of year 2025 for elimination of TB from the country, 5 years ahead of the Sustainable Development Goal of 2030. Last few years, India has made significant improvements, towards elimination of tuberculosis from the country in the form of bold policies and unprecedented political commitment. While COVID-19 has resulted in setbacks for TB elimination efforts, it has also offered an opportunity to revisit and structurally redesign the public health infrastructure/system in our country. The dream of TB elimination is possible with active participation of all stakeholders and community at large coupled with accelerated development of new diagnostics, drugs, and development of a new TB vaccine. COVID-19 pandemic has shown that vaccines can be developed in a year, contrarily, the lack of a TB vaccine is deterrent in the efforts towards a TB free world. A progress towards TB elimination would require potential contribution of novel TB vaccine. Now, is the time for mobilization towards a TB vaccine to make an impact towards our end TB goal. Published by Elsevier B.V. on behalf of Tuberculosis Association of India. 2022-07 2021-08-17 /pmc/articles/PMC9231385/ /pubmed/35760473 http://dx.doi.org/10.1016/j.ijtb.2021.08.018 Text en © 2021 Published by Elsevier B.V. on behalf of Tuberculosis Association of India. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Editorial Mandal, Sudarsan Towards building a tuberculosis free world |
title | Towards building a tuberculosis free world |
title_full | Towards building a tuberculosis free world |
title_fullStr | Towards building a tuberculosis free world |
title_full_unstemmed | Towards building a tuberculosis free world |
title_short | Towards building a tuberculosis free world |
title_sort | towards building a tuberculosis free world |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231385/ https://www.ncbi.nlm.nih.gov/pubmed/35760473 http://dx.doi.org/10.1016/j.ijtb.2021.08.018 |
work_keys_str_mv | AT mandalsudarsan towardsbuildingatuberculosisfreeworld |